{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:44:22Z","timestamp":1789908262363,"version":"4.0.1"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["ejso.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology (EJSO)"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/j.ejso.2017.05.015","type":"journal-article","created":{"date-parts":[[2017,5,29]],"date-time":"2017-05-29T00:00:16Z","timestamp":1496016016000},"page":"1932-1938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Prediction of clinical outcome using blood flow volume in the superior mesenteric artery in patients with pseudomyxoma peritonei treated by cytoreductive surgery"],"prefix":"10.1016","volume":"43","author":[{"given":"A.","family":"Dohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Barral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Eveno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Lo Dico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kaci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9216-2231","authenticated-orcid":false,"given":"A.","family":"Pasteur-Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Soyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Pocard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Bonnin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejso.2017.05.015_bib1","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.ejso.2007.04.002","article-title":"Appendiceal neoplasms and pseudomyxoma peritonei: a population based study","volume":"34","author":"Smeenk","year":"2008","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2017.05.015_bib2","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4251\/wjgo.v2.i1.44","article-title":"Pseudomyxoma peritonei","volume":"2","author":"Bevan","year":"2010","journal-title":"World J Gastrointest Oncol"},{"key":"10.1016\/j.ejso.2017.05.015_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S1470-2045(05)70539-8","article-title":"New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?","volume":"7","author":"Sugarbaker","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejso.2017.05.015_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/978-1-4613-1247-5_23","article-title":"Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis","volume":"82","author":"Jacquet","year":"1996","journal-title":"Cancer Treat Res"},{"key":"10.1016\/j.ejso.2017.05.015_bib5","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1136\/jclinpath-2012-200843","article-title":"Pathology and prognosis in pseudomyxoma peritonei: a review of 274 cases","volume":"65","author":"Carr","year":"2012","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.ejso.2017.05.015_bib6","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.ejso.2015.04.005","article-title":"The role of baseline inflammatory-based scores and serum tumor markers to risk stratify pseudomyxoma peritonei patients treated with cytoreduction (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC)","volume":"41","author":"Kusamura","year":"2015","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2017.05.015_bib7","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1477-7819-6-118","article-title":"Experience with adjuvant chemotherapy for pseudomyxoma peritonei secondary to mucinous adenocarcinoma of the appendix with oxaliplatin\/fluorouracil\/leucovorin (FOLFOX4)","volume":"6","author":"Chen","year":"2008","journal-title":"World J Surg Oncol"},{"key":"10.1016\/j.ejso.2017.05.015_bib8","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.4161\/cbt.8.15.8943","article-title":"Successful antiangiogenic combination therapy for pseudomyxoma peritonei with bevacizumab and capecitabine","volume":"8","author":"Sun","year":"2009","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.ejso.2017.05.015_bib9","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1097\/01.sla.0000152015.76731.1f","article-title":"Long-term survival following treatment of pseudomyxoma peritonei: an analysis of surgical therapy","volume":"241","author":"Miner","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2017.05.015_bib10","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejso.2017.05.015_bib11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.crohns.2012.07.002","article-title":"Anti-TNFalpha therapy early improves hemodynamics in local intestinal and extraintestinal circulations in active Crohn's disease","volume":"7","author":"Bonnin","year":"2013","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1016\/j.ejso.2017.05.015_bib12","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1158\/0008-5472.CAN-08-2484","article-title":"Angiotensinogen delays angiogenesis and tumor growth of hepatocarcinoma in transgenic mice","volume":"69","author":"Vincent","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.ejso.2017.05.015_bib13","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.ultrasmedbio.2015.10.012","article-title":"Preclinical assessment of the efficacy of anti-angiogenic therapies in hepatocellular carcinoma","volume":"42","author":"Barral","year":"2016","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.ejso.2017.05.015_bib14","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.ultrasmedbio.2006.09.010","article-title":"Ultrasonic assessment of hepatic blood flow as a marker of mouse hepatocarcinoma","volume":"33","author":"Bonnin","year":"2007","journal-title":"Ultrasound Med Biol"},{"key":"10.1016\/j.ejso.2017.05.015_bib15","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.jhep.2011.01.033","article-title":"Neuropilin-1 is upregulated in hepatocellular carcinoma and contributes to tumour growth and vascular remodelling","volume":"55","author":"Berge","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.ejso.2017.05.015_bib16","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1016\/j.ajpath.2014.03.004","article-title":"Orthotopic animal model of pseudomyxoma peritonei: an in\u00a0vivo model to test anti-angiogenic drug effects","volume":"184","author":"Dohan","year":"2014","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ejso.2017.05.015_bib17","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1097\/00000658-199502000-00002","article-title":"Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy","volume":"221","author":"Sugarbaker","year":"1995","journal-title":"Ann Surg"},{"key":"10.1016\/j.ejso.2017.05.015_bib18","series-title":"Precision of test method (BS5497, part 1)","author":"British Standards Institution","year":"1979"},{"key":"10.1016\/j.ejso.2017.05.015_bib19","series-title":"Cardiovascular system: blood vessels","first-page":"849","article-title":"Human anatomy and physiology","author":"Marieb","year":"2014"},{"key":"10.1016\/j.ejso.2017.05.015_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejso.2009.09.001","article-title":"Pseudomyxoma peritonei: role of 18F-FDG PET in preoperative evaluation of pathological grade and potential for complete cytoreduction","volume":"36","author":"Passot","year":"2010","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.ejso.2017.05.015_bib21","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2214\/AJR.07.2018","article-title":"Mucinous appendiceal neoplasms: preoperative MR staging and classification compared with surgical and histopathologic findings","volume":"190","author":"Low","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.ejso.2017.05.015_bib22","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.humpath.2016.02.022","article-title":"Expression of CEA, CA19-9, CA125, and EpCAM in pseudomyxoma peritonei","volume":"54","author":"Nummela","year":"2016","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ejso.2017.05.015_bib23","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1245\/s10434-012-2788-2","article-title":"Surveillance MR imaging is superior to serum tumor markers for detecting early tumor recurrence in patients with appendiceal cancer treated with surgical cytoreduction and HIPEC","volume":"20","author":"Low","year":"2013","journal-title":"Ann Surg Oncol"}],"container-title":["European Journal of Surgical Oncology (EJSO)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798317304985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798317304985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T08:05:25Z","timestamp":1535789125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798317304985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S0748798317304985"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2017.05.015","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of clinical outcome using blood flow volume in the superior mesenteric artery in patients with pseudomyxoma peritonei treated by cytoreductive surgery","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology (EJSO)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2017.05.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}